Table 4.
Antibiotic | Pharmacodynamic | Pharmacokinetics | Dosing (with normal hepatic and renal function) |
---|---|---|---|
Piperacillin/tazobactam | T > MIC | Hydrophilic, renal clearance | 4.5 g every 6 h |
Ceftazidime | T > MIC | Hydrophilic, renal clearance | 6 g every 24 h |
Cefepime | T > MIC | Hydrophilic, renal clearance | 2 g every 8 h |
Aztreonam | T > MIC | Hydrophilic, renal clearance | 1 g (2 g) every 8 h |
Meropenem | T > MIC | Renal clearance | 1 g (2 g) every 8 h |
Tigecycline | AUC/MIC | Hepatic and renal clearance | 100–200 mg loading dose, then 50–100 mg every 12 h |
entamicin | Cmax/MIC | Hydrophilic, renal clearance | 7 mg/kg/day every 24 h |
Amikacin | Cmax/MIC | Hydrophilic, renal clearance | 25–30 mg/kg/day every 24 h |
Colistin | AUC/MIC | Hydrophilic, renal clearance | 9 MU loading dose, then 4.5 MU every 8–12 h |
Fosfomycin | AU/MIC for Gram negatives, T > MIC for Gram Positives | Hydrophilic, hepatic clearance | 4–6 g every 6 h CI |
Vancomycin | AUC/MIC | Renal clearance | 15–30 mg/kg loading dose, then 30–60 mg/kg every 12 h |
Linezolid | AUC/MIC | Lipophilic, hepatic clearance | 600 mg every 12 h |
eftaroline | T > MIC | Hydrophilic, renal clearance | 600 mg q12 h, IV |
Ceftobiprole | T > MIC | Hydrophilic, renal clearance | 500 mg q8 h IV |
Ceftazidime/avibactam | T > MIC | Hydrophilic, renal clearance | 2.5 g q8 h IV |
Ceftolozane/tazobactam | T > MIC | Hydrophilic, renal clearance | 1.5 g q8 h/3 g q8 h |
Meropenem/vaborbactam | T > MIC | Hydrophilic, renal clearance | 2 g/2 g q8 h |
AUC: Area under the receiver operating characteristic curve; ICUs: Intensive care units; IV: Intravenousinjection; MIC: Minimum inhibitor concentration; T: Time.